157 related articles for article (PubMed ID: 11751068)
41. Parathyroid variants: US evaluation.
Randel SB; Gooding GA; Clark OH; Stein RM; Winkler B
Radiology; 1987 Oct; 165(1):191-4. PubMed ID: 3306784
[TBL] [Abstract][Full Text] [Related]
42. Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia.
Matsushita H; Hara M; Endo Y; Shishiba Y; Hara S; Ubara Y; Nakazawa H; Suzuki N; Kawaminami K; Kido T; Li Q; Grimelius L
Kidney Int; 1999 Jan; 55(1):130-8. PubMed ID: 9893121
[TBL] [Abstract][Full Text] [Related]
43. Expression of parathyroid hormone-related protein (PTHrP) in parathyroid tissue under normal and pathological conditions.
Kitazawa R; Kitazawa S; Maeda S; Kobayashi A
Histol Histopathol; 2002 Jan; 17(1):179-84. PubMed ID: 11813867
[TBL] [Abstract][Full Text] [Related]
44. [Morphologic changes in the parathyroid glands in primary hyperparathyroidism].
Odinokova VA; Dmitrieva NP; Kalinin AP; Astakhov AF
Arkh Patol; 1976; 38(7):18-24. PubMed ID: 1016092
[TBL] [Abstract][Full Text] [Related]
45. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients?
Lafage-Proust MH
Kidney Int; 2010 Mar; 77(5):390-2. PubMed ID: 20150940
[TBL] [Abstract][Full Text] [Related]
46. Expression of cellular retinol- and retinoic acid-binding proteins in normal and pathologic human parathyroid glands.
Melhus H; Li Q; Nordlinder H; Farnebo LO; Grimelius L
Endocr Pathol; 2001; 12(4):423-7. PubMed ID: 11914476
[TBL] [Abstract][Full Text] [Related]
47. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
[TBL] [Abstract][Full Text] [Related]
48. Anatomy and histopathology of human parathyroid glands.
Grimelius L; Akerström G; Johansson H; Bergström R
Pathol Annu; 1981; 16(Pt 2):1-24. PubMed ID: 7036057
[No Abstract] [Full Text] [Related]
49. Value of high resolution real-time ultrasonography in secondary hyperparathyroidism.
Clark OH; Stark DA; Duh QY; Arnaud CD; Gooding GA
Am J Surg; 1985 Jul; 150(1):9-17. PubMed ID: 3893184
[TBL] [Abstract][Full Text] [Related]
50. Epidermal growth factor receptor status in hyperparathyroidism: immunocytochemical and In situ hybridization study.
Sadler GP; Morgan JM; Jasani B; Douglas-Jones A; Wheeler MH
World J Surg; 1996 Sep; 20(7):736-42; discussion 742-3. PubMed ID: 8678944
[TBL] [Abstract][Full Text] [Related]
51. [Hyperparathyroidism--a comparison of morphologic findings in the parathyroid with clinical data on 195 patients].
Thiele J; Ringe B; Jonas M; Hesch RD
Pathologe; 1986 Jan; 7(1):36-49. PubMed ID: 3952065
[No Abstract] [Full Text] [Related]
52. [Pathohistologic parathyroid gland diagnosis in hyperparathyroidism].
Gabbert H; Thoenes W
Pathologe; 1982 Sep; 3(5):287-97. PubMed ID: 7145867
[No Abstract] [Full Text] [Related]
53. Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism.
Oka T; Yoshioka T; Shrestha GR; Koide T; Sonoda T; Hosokawa S; Onoe K; Sakurai M
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):53-60. PubMed ID: 3131956
[TBL] [Abstract][Full Text] [Related]
54. Expression of chromogranin-A messenger ribonucleic acid in parathyroid tissue from patients with primary hyperparathyroidism.
Levine MA; Dempsey MA; Helman LJ; Ahn TG
J Clin Endocrinol Metab; 1990 Jun; 70(6):1668-73. PubMed ID: 2347900
[TBL] [Abstract][Full Text] [Related]
55. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism.
Zhang P; Duchambon P; Gogusev J; Nabarra B; Sarfati E; Bourdeau A; Drüeke TB
Kidney Int; 2000 Feb; 57(2):437-45. PubMed ID: 10652020
[TBL] [Abstract][Full Text] [Related]
56. Mast cells in parathyroid glands of hyperparathyroidism.
Anderson TJ
J Clin Pathol; 1974 Jan; 27(1):31-4. PubMed ID: 4821095
[TBL] [Abstract][Full Text] [Related]
57. Parathyroid Pathology.
Guilmette J; Sadow PM
Surg Pathol Clin; 2019 Dec; 12(4):1007-1019. PubMed ID: 31672291
[TBL] [Abstract][Full Text] [Related]
58. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
59. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure.
Martín-Salvago M; Villar-Rodríguez JL; Palma-Alvarez A; Beato-Moreno A; Galera-Davidson H
Endocr Pathol; 2003; 14(1):61-70. PubMed ID: 12746564
[TBL] [Abstract][Full Text] [Related]
60. Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening.
Lundgren E; Ridefelt P; Akerström G; Ljunghall S; Rastad J
World J Surg; 1996 Sep; 20(7):727-34; discussion 735. PubMed ID: 8678973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
